
United States · Information technology & services startup
Biobot Analytics is a biotechnology company based in Cambridge, Massachusetts, specializing in wastewater-based epidemiology.
Funding reportedLast round: Venture (Round not Specified)
Biobot Analytics is a biotechnology company based in Cambridge, Massachusetts, specializing in wastewater-based epidemiology.
Founded in 2017 at MIT, the company uses molecular technologies and artificial intelligence to analyze wastewater samples. This analysis helps monitor public health by measuring the concentration of pathogens, illicit drugs, and other health indicators in communities. The company offers a range of services, including wastewater testing kits, lab analysis, and subscription data access. Their platform provides real-time monitoring of community health trends, aiding government agencies, public health officials, and local municipalities in responding to disease outbreaks and health disparities. Biobot's products include tools for tracking opioid use and COVID-19 trends, as well as expanded pathogen detection for various viruses. With operations in nearly 1,000 locations across the U.S. and beyond, Biobot aims to build a global public health database to enhance early warning systems for disease outbreaks.
Funding, as reported
From Biobot Analytics's own website: 4 on the team.
What they build
Known for
community health monitoringhealth carewastewater sequencingmolecular technologiesreal-time dataenterprisescommunity disease burdenwastewater-based epidemiologyinformation technology & servicesenterprise softwarepublic health resourcesenvironmental serviceshospital & health caredisease clusterspublic healthai analysis
Built with from their website
Yoast SEOGoogle Tag ManagerAmazon CloudFrontWordPress.orgAtlassianPWAFont AwesomeElementorGoogle WorkspaceViewport Meta
YoastGoogle AnalyticsHTTP/3WP EngineHubspotMiroGoogle Analytics 4Amazon AWS
Add your raise, your deck and your story, and put Biobot Analytics in front of investors. Or tell us what we have wrong.